Trials / Unknown
UnknownNCT05770635
Polyvinyl Alcohol Embolization Microspheres
A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Safety and Efficacy of Polyvinyl Alcohol Embolization Microspheres for Transarterial Chemoembolization of Primary Liver Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 224 (estimated)
- Sponsor
- Shanghai Huihe Medical Technology Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and efficacy of polyvinyl alcohol embolization microspheres developed and manufactured by Shanghai Huihe Medical Technology Co., LTD. (hereinafter referred to as Huihe Medical) for transarterial chemoembolization of primary liver cancer using a prospective, multi-center, randomized controlled method
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Embosphere and chemotherapy drug | chemotherapeutic drug + embolic Embosphere;Iodide is selected according to the subject's condition |
| DEVICE | Polyvinyl alcohol embolization microspheres (Huihe Medical) and chemotherapy drug | chemotherapy drug+Polyvinyl alcohol embolization microspheres (Huihe Medical);Iodide is selected according to the subject's condition |
Timeline
- Start date
- 2022-12-28
- Primary completion
- 2024-12-28
- Completion
- 2024-12-28
- First posted
- 2023-03-15
- Last updated
- 2023-03-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05770635. Inclusion in this directory is not an endorsement.